Charleston County Public Library

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

(193) Low Intensity Shockwave Therapy in Combination with Phosphodiesterase-5 Inhibitors is an Effective and Safe Treatment Option in Patients with Vasculogenic ED who are PDE5i Nonresponders: A Multicenter Single-Arm Clinical Trial.

Authors : Palmieri, A¹ (AUTHOR); Arcaniolo, D² (AUTHOR); Palumbo, F³ (AUTHOR)

Subjects: *PHOSPHODIESTERASE-5 inhibitors; *PHOSPHODIESTERASE inhibitors; *IMPOTENCE

Source: Journal of Sexual Medicine. 2024 Supplement, Vol. 21, p1-2. 2p.

Record details

Read More Add to Saved list

Academic Journal

Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism.

Authors : Wang, Chunlin¹ (AUTHOR); Zhang, Hui¹ (AUTHOR); Wang, Fu² (AUTHOR)

Subjects: *PHOSPHODIESTERASE inhibitors; *PHOSPHODIESTERASE-5 inhibitors; *OLDER patients

Source: Aging Male. Dec2024, Vol. 27 Issue 1, p1-14. 14p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Deciphering phosphodiesterase-5 inhibitors from Aframemum melegueta: computational models against erectile dysfunction.

Authors : Omoboyowa, Damilola Alex

Subjects: PHOSPHODIESTERASE inhibitors; PHOSPHODIESTERASE-5 inhibitors; IMPOTENCE

Source: In Silico Pharmacology; 11/9/2024, Vol. 12 Issue 2, p1-15, 15p

Record details

Read More Add to Saved list

Academic Journal

"Might anti-inflammatory priming enhance the anti erectile dysfunction efficacy of pde5 inhibitors? An exploratory cohort study".

Authors : Giacalone, Ninfa A.¹ (AUTHOR); Raichi, Dr. Mauro² (AUTHOR)

Subjects: *PHOSPHODIESTERASE inhibitors; *PHOSPHODIESTERASE-5 inhibitors; *IMPOTENCEMILAN (Italy)

Source: Journal of Sexual Medicine. 2022 Supplement 4, Vol. 19 Issue 11, pS91-S92. 2p.

Record details

Read More Add to Saved list

Academic Journal

Phosphodiesterase-5 Inhibitors and Survival in Men With Coronary Artery Disease.

Authors : Maas, Renke¹ (AUTHOR) ; Rodionov, Roman N.^2,3 (AUTHOR)

Subjects: *PHOSPHODIESTERASE-5 inhibitors; *CORONARY disease; *PROSTAGLANDIN E1

Source: Journal of the American College of Cardiology (JACC). Mar2021, Vol. 77 Issue 12, p1551-1553. 3p.

Record details

Read More Add to Saved list

Academic Journal

Inhibidores de la fosfodiesterasa 5 y salud cardiovascular: del riesgo a la seguridad y a la potencial protección.

Authors : Marconi, Marcelo¹ ; Fuentes, Ignacio²; Quiñones, Paola²

Subjects: PHOSPHODIESTERASE inhibitors; MYOCARDIAL infarction; IMPOTENCE

Source: Revista Chilena de Urologia. abr-jun2024, Vol. 89 Issue 2, p11-14. 4p.

Record details

Read More Add to Saved list

Academic Journal

Development of a specific fragment pattern-based quadrupole-Orbitrap mass spectrometry method to screen adulterated products of phosphodiesterase-5 inhibitors and their analogues.

Authors : Lee, Ji Hyun; Park, Han Na; Park, Seongsoo

Subjects: PHOSPHODIESTERASE-5 inhibitors; MASS spectrometry; IMPOTENCE

Source: Science & Justice; Jul2019, Vol. 59 Issue 4, p433-441, 9p

Record details

Read More Add to Saved list

Academic Journal

Assessment of the intracavernosal injection platelet‐rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non‐responding to on‐demand oral PDE5 inhibitors.

Authors : Zaghloul, Ahmed S.¹ (AUTHOR) ; El‐Nashaar, Abdelrahman M.¹ (AUTHOR); Said, Shady Z.¹ (AUTHOR)

Subjects: *PHOSPHODIESTERASE inhibitors; *PHOSPHODIESTERASE-5 inhibitors; *PLATELET-rich plasma

Source: Andrologia. Jul2022, Vol. 54 Issue 6, p1-7. 7p.

Record details

Read Online Read More Add to Saved list

Academic Journal

The Phosphodiesterase-5 Inhibitors and Prostate Cancer – What We Rely Know About It?

Authors : Simic, Dejan¹ (AUTHOR); Spasic, Aleksandar¹ (AUTHOR); Jovanovic, Mirko¹ (AUTHOR)

Subjects: *PHOSPHODIESTERASE inhibitors; *PHOSPHODIESTERASE-5 inhibitors; *PROSTATE cancer

Source: Serbian Journal of Experimental & Clinical Research. Jun2022, Vol. 23 Issue 2, p175-184. 10p.

Record details

Read More Add to Saved list

Academic Journal

Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy.

Authors : Gandaglia, G¹; Gallina, A¹; Suardi, N¹

Subjects: *IMPOTENCE; *PHOSPHODIESTERASE-5 inhibitors; *PROSTATECTOMY

Source: International Journal of Impotence Research. Nov/Dec2014, Vol. 26 Issue 6, p201-204. 4p.

Record details

Read Online Read More Add to Saved list

menu

Search Results

Your Filters

(193) Low Intensity Shockwave Therapy in Combination with Phosphodiesterase-5 Inhibitors is an Effective and Safe Treatment Option in Patients with Vasculogenic ED who are PDE5i Nonresponders: A Multicenter Single-Arm Clinical Trial.

Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism.

Deciphering phosphodiesterase-5 inhibitors from Aframemum melegueta: computational models against erectile dysfunction.

"Might anti-inflammatory priming enhance the anti erectile dysfunction efficacy of pde5 inhibitors? An exploratory cohort study".

Phosphodiesterase-5 Inhibitors and Survival in Men With Coronary Artery Disease.

Inhibidores de la fosfodiesterasa 5 y salud cardiovascular: del riesgo a la seguridad y a la potencial protección.

Development of a specific fragment pattern-based quadrupole-Orbitrap mass spectrometry method to screen adulterated products of phosphodiesterase-5 inhibitors and their analogues.

Assessment of the intracavernosal injection platelet‐rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non‐responding to on‐demand oral PDE5 inhibitors.

The Phosphodiesterase-5 Inhibitors and Prostate Cancer – What We Rely Know About It?

Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy.

Contact CCPL

Patron Login

menu

Search Results

Your Filters

Engage with CCPL

Contact CCPL